Basic Information
| RNALocate ID: | RLID:11000980 |
| RNA Symbol: | hsa-miR-98-5p |
| Localization: | Exosome |
RNA Information
| RNA Name: | hsa-miR-98-5p |
| RNA ID: | miRBase:MIMAT0000096 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| PubMed ID: | 22211110 |
| Tissue/Cell Line: | Breast milk |
| Method: | Next-generation RNA sequencing |
|
The expression profile of selected miRNAs in breast milk exosomes. Originally published in Int J Biol Sci. Zhou Q, et al, 2012. Reproduced under the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) |
|
| Description: | Distribution and characterization of miRNAs in breast milk exosomes. (A) Distribution of pre-miRNAs. Out of 1,424 pre-miRNAs deposited in miRBase 17.0 (blue circle), 87 (6.11%) pre-miRNAs have been designated as immune-related pre-miRNAs based on annotation in the Pathway Central database (SABiosciences, MD, USA). Immune-related pre-miRNAs (59 of 452, 13.05%) are enriched in breast milk exosomes (red circle). χ2 test: Number of immune-related miRNAs and others detected in breast milk exosomes compared with the total entries in miRBase 17.0. (B) Top ten most highly expressed unique miRNAs. Plot of the unique miRNAs (starting from the miRNA with the highest counts, x-axis) versus their cumulative % of the total counts from 602 unique miRNAs detected in breast milk exosomes for each small RNA library. Values are means ± s.d. The dashed horizontal line at 62.3% represents the level of the top ten unique miRNAs and the % of individual miRNAs is marked by the gray line. (C-E) The expression profile of selected miRNAs in breast milk exosomes. (C) 59 immune-related pre-miRNAs; (D) miR-17-92 cluster and paralogous clusters, and (E) ten well-characterized tissue-specific pre-miRNAs. Data are collected from Figure 2. |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:01001422 | Cytoplasm | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:01001423 | Mitochondrion | Cell line (HEK-293|HeLa) | 22984580 |
| RLID:01001424 | Nucleus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:11000978 | Exosome | Human cervical cancer cell line (HeLa) | 25760330 |
| RLID:11000979 | Exosome | Primary dendritic cells|T cell line (J77) | 21505438 |
| RLID:11000981 | Exosome | Brain tissue | 23382797 |
| RLID:11000982 | Exosome | Plasma | 23663360 |
| RLID:11000983 | Exosome | Human mast cell line (HMC-1) | 24009880 |
| RLID:11000984 | Microvesicle | Plasma | 23077538 |
| RLID:11000985 | Microvesicle | Seminal plasma | 23539611 |
| RLID:11000986 | Microvesicle | Colon cancer cell line (LIM1863) | 25330373 |
| RLID-D:11000030 | Exosome | B lymphoblastoid cells|Endothelial cells|Epithelial cells|Mast cells|Tongue tissue | |
| RLID-D:11000295 | Microvesicle | Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-98-5p | Splenic marginal zone lymphoma | MNDR-E-MI-72818 |
| MNDR | hsa-miR-98-5p | Multiple sclerosis chronic progressive | MNDR-E-MI-72819 |
| MNDR | hsa-miR-98-5p | Oral squamous cell carcinoma | MNDR-E-MI-72820 |
| MNDR | hsa-miR-98-5p | Medulloblastoma | MNDR-E-MI-72821 |
| MNDR | hsa-miR-98-5p | Ovarian clear cell carcinoma | MNDR-E-MI-72822 |
| MNDR | hsa-miR-98-5p | Lymphoma | MNDR-E-MI-72823 |
| MNDR | hsa-miR-98-5p | Lymphoma non-hodgkin | MNDR-E-MI-72824 |
| MNDR | hsa-miR-98-5p | Estrogen-receptor positive breast cancer | MNDR-E-MI-72825 |
| MNDR | hsa-miR-98-5p | Estrogen-receptor negative breast cancer | MNDR-E-MI-72826 |
| MNDR | hsa-miR-98-5p | Progesterone-receptor positive breast cancer | MNDR-E-MI-72827 |
| MNDR | hsa-miR-98-5p | Progesterone-receptor negative breast cancer | MNDR-E-MI-72828 |
| MNDR | hsa-miR-98-5p | Her2-receptor positive breast cancer | MNDR-E-MI-72829 |
| MNDR | hsa-miR-98-5p | Breast cancer luminal | MNDR-E-MI-72830 |
| MNDR | hsa-miR-98-5p | Niemann-pick disease type c | MNDR-E-MI-72831 |
| MNDR | hsa-miR-98-5p | Precursor cell lymphoblastic leukemia-lymphoma | MNDR-E-MI-72832 |
| MNDR | hsa-miR-98-5p | B cell acute lymphoblastic leukemia | MNDR-E-MI-72833 |
| MNDR | hsa-miR-98-5p | Dermatomyositis | MNDR-E-MI-72834 |
| MNDR | hsa-miR-98-5p | Prostate cancer | MNDR-E-MI-72835 |
| MNDR | hsa-miR-98-5p | Gastric cancer | MNDR-E-MI-72836 |
| MNDR | hsa-miR-98-5p | Gastric lymphoma | MNDR-E-MI-72837 |
| MNDR | hsa-miR-98-5p | Alzheimer disease | MNDR-E-MI-72838 |
| MNDR | hsa-miR-98-5p | Intracranial aneurysm | MNDR-E-MI-72839 |
| MNDR | hsa-miR-98-5p | Dysautonomia familial | MNDR-E-MI-72840 |
| MNDR | hsa-miR-98-5p | Leukemia | MNDR-E-MI-72841 |
| MNDR | hsa-miR-98-5p | Cardiovascular disease | MNDR-E-MI-72842 |
| MNDR | hsa-miR-98-5p | Lung cancer | MNDR-E-MI-72843 |
| MNDR | hsa-miR-98-5p | Endometrial cancer | MNDR-E-MI-72844 |
| MNDR | hsa-miR-98-5p | Down syndrome | MNDR-E-MI-72845 |
| MNDR | hsa-miR-98-5p | Parkinson disease | MNDR-E-MI-72846 |
| MNDR | hsa-miR-98-5p | Machado-joseph disease | MNDR-E-MI-72847 |
| MNDR | hsa-miR-98-5p | Niemann-pick disease | MNDR-E-MI-72848 |
| MNDR | hsa-miR-98-5p | Basal-like breast cancer | MNDR-E-MI-72849 |
| MNDR | hsa-miR-98-5p | Pancreatic cancer | MNDR-E-MI-72850 |
| MNDR | hsa-miR-98-5p | Melanoma | MNDR-E-MI-72851 |
| MNDR | hsa-miR-98-5p | Rectum adenocarcinoma | MNDR-E-MI-72852 |
| MNDR | hsa-miR-98-5p | Nephroblastoma | MNDR-E-MI-72853 |
| MNDR | hsa-miR-98-5p | Colon cancer | MNDR-E-MI-72854 |
| MNDR | hsa-miR-98-5p | Colon adenocarcinoma | MNDR-E-MI-72855 |
| MNDR | hsa-miR-98-5p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-72856 |
| MNDR | hsa-miR-98-5p | Familial ovarian cancer | MNDR-E-MI-72857 |
| MNDR | hsa-miR-98-5p | Prostate adenocarcinoma | MNDR-E-MI-72858 |
| MNDR | hsa-miR-98-5p | Carcinoma ductal breast | MNDR-E-MI-72859 |
| MNDR | hsa-miR-98-5p | Glioblastoma | MNDR-E-MI-72860 |
| MNDR | hsa-miR-98-5p | Astrocytoma | MNDR-E-MI-72861 |
| MNDR | hsa-miR-98-5p | Glioma | MNDR-E-MI-72862 |
| MNDR | hsa-miR-98-5p | Amyotrophic lateral sclerosis | MNDR-E-MI-72863 |
| MNDR | hsa-miR-98-5p | Osteosarcoma | MNDR-E-MI-72864 |
| MNDR | hsa-miR-98-5p | Liposarcoma | MNDR-E-MI-72865 |
| MNDR | hsa-miR-98-5p | Inclusion body myositis | MNDR-E-MI-72866 |
| MNDR | hsa-miR-98-5p | Pancreatic ductal adenocarcinoma | MNDR-E-MI-72867 |
| MNDR | hsa-miR-98-5p | Meningioma | MNDR-E-MI-72868 |
| MNDR | hsa-miR-98-5p | Lung squamous cell carcinoma | MNDR-E-MI-72869 |
| MNDR | hsa-miR-98-5p | Carcinoma lung non-small-cell | MNDR-E-MI-72870 |
| MNDR | hsa-miR-98-5p | Lung adenocarcinoma | MNDR-E-MI-72871 |
| MNDR | hsa-miR-98-5p | Adrenocortical carcinoma | MNDR-E-MI-72872 |
| MNDR | hsa-miR-98-5p | Thyroid carcinoma | MNDR-E-MI-72873 |
| MNDR | hsa-miR-98-5p | Bladder urothelial carcinoma | MNDR-E-MI-72874 |
| MNDR | hsa-miR-98-5p | Pancreatic adenocarcinoma | MNDR-E-MI-72875 |
| MNDR | hsa-miR-98-5p | Carcinoma renal cell | MNDR-E-MI-72876 |
| MNDR | hsa-miR-98-5p | Kidney renal papillary cell carcinoma | MNDR-E-MI-72877 |
| MNDR | hsa-miR-98-5p | Intrahepatic cholangiocarcinoma | MNDR-E-MI-72878 |
| MNDR | hsa-miR-98-5p | Cholangiocarcinoma | MNDR-E-MI-72879 |
| MNDR | hsa-miR-98-5p | Esophageal cancer | MNDR-E-MI-72880 |
| MNDR | hsa-miR-98-5p | Lung small cell carcinoma | MNDR-E-MI-72881 |
| MNDR | hsa-miR-98-5p | Synovial sarcoma | MNDR-E-MI-72882 |
| MNDR | hsa-miR-98-5p | Head and neck squamous cell carcinoma | MNDR-E-MI-72883 |
| MNDR | hsa-miR-98-5p | Pulmonary arterial hypertension | MNDR-E-MI-72884 |
| MNDR | hsa-miR-98-5p | Breast invasive carcinoma | MNDR-E-MI-72885 |
| MNDR | hsa-miR-98-5p | Hepatocellular carcinoma | MNDR-E-MI-72886 |
| MNDR | hsa-miR-98-5p | Familiar ovarian carcinoma | MNDR-E-MI-72887 |
| MNDR | hsa-miR-98-5p | B-cell lymphoma | MNDR-E-MI-72888 |
| MNDR | hsa-miR-98-5p | Rheumatoid arthritis | MNDR-E-MI-72889 |
| MNDR | hsa-miR-98-5p | T-cell leukemia | MNDR-E-MI-72890 |
| MNDR | hsa-miR-98-5p | Malignant pleural mesothelioma | MNDR-E-MI-72891 |
| MNDR | hsa-miR-98-5p | Retinoblastoma | MNDR-E-MI-72892 |
| MNDR | hsa-miR-98-5p | Myocarditis | MNDR-E-MI-72893 |
| MNDR | hsa-miR-98-5p | Hodgkin lymphoma | MNDR-E-MI-72894 |
| MNDR | hsa-miR-98-5p | Burkitt lymphoma | MNDR-E-MI-72895 |
| MNDR | hsa-miR-98-5p | Neuromyelitis optica | MNDR-E-MI-72896 |
| MNDR | hsa-miR-98-5p | Degenerative disc disease | MNDR-E-MI-72897 |
| MNDR | hsa-miR-98-5p | Acute myelogenous leukemia | MNDR-E-MI-72898 |
| MNDR | hsa-miR-98-5p | Colorectal cancer | MNDR-E-MI-72899 |
| MNDR | hsa-miR-98-5p | Nasopharyngeal carcinoma | MNDR-E-MI-72900 |
| MNDR | hsa-miR-98-5p | Multiple myeloma | MNDR-E-MI-72901 |
| MNDR | hsa-miR-98-5p | Myotrophin | MNDR-E-MI-72902 |
| MNDR | hsa-miR-98-5p | Nasopharyngeal cancer | MNDR-E-MI-72903 |
| MNDR | hsa-miR-98-5p | Aids dementia complex | MNDR-E-MI-72904 |
| MNDR | hsa-miR-98-5p | Epstein-barr virus infections | MNDR-E-MI-72905 |
| MNDR | hsa-miR-98-5p | Sarcopenia | MNDR-E-MI-72906 |
| MNDR | hsa-miR-98-5p | Breast cancer her3+ negative | MNDR-E-MI-72907 |
| MNDR | hsa-miR-98-5p | Solid-pseudopapillary neoplasm of pancreas | MNDR-E-MI-72908 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | ACADM | Homo sapiens | RR00032695 |
TOP